Answer
Praluent (alirocumab) is indicated for adult primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, alongside diet, with a statin with or without other lipid-lowering therapies when maximum tolerated statin doses fail LDL-C goals, or alone/with other lipid-lowering therapies when statins are contraindicated or not tolerated.
Sources for this answer
- Praluent 75 mg solution for injection in pre filled penSANOFI · emc · SmPC §4.1 Therapeutic Indications · Version 7Document updated
Sources checked